Subscription rights in Pharma Equity Group A/S will be admitted to trading and
official listing on Nasdaq Copenhagen as per 2 March 2023. As of the same date,
ISIN DK0061155009 (PEG) will be traded excl. of subscription rights.
ISIN: DK0062267605
--------------------------------------------------------------------------------
Name: Pharma Equity Group, T-ret
--------------------------------------------------------------------------------
Proportion: 2:1 (DK)
Shareholders in Pharma Equity Group A/S will be allocated 1
subscription right for each existing share. 2 subscription
rights will entitle the shareholder to subscribe for 1 new
share at the subscription price
--------------------------------------------------------------------------------
Trade in 2 March 2023 - 15 March 2023
subscription
rights (both
days included):
--------------------------------------------------------------------------------
Orderbook ID: 285510
--------------------------------------------------------------------------------
Orderbook Code: PEG T
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Market Segment / OMX CPH Rights (subscription & bonus)/15
no
--------------------------------------------------------------------------------
Tick Size /no MiFID II tick size table/230
--------------------------------------------------------------------------------
MIC Code XCSE
--------------------------------------------------------------------------------
Pharma Equity Group A/S makes a rights issue of up to 22,189,810 new shares
with a nominal value of DKK 1 per share. Subscription price is DKK 1 per share
of DKK 1. Subscription period: 6 March - 17 March 2023, both days included.
For further information, please contact: Surveillance, tel. +45 33 93 33 66© 2023 GlobeNewswire
